Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / CALL
-
Number of holders
-
1
-
Total 13F shares, excl. options
-
5,650
-
Shares change
-
-11,350
-
Total reported value, excl. options
-
$1,652,000
-
Value change
-
+$1,408,000
-
Number of buys
-
1
-
Number of sells
-
-1
-
Price
-
$292.39
Significant Holders of VALEANT PHARMACEUTICALS INTL - CALL as of Q4 2017
8 filings reported holding 91911K902 - VALEANT PHARMACEUTICALS INTL - CALL as of Q4 2017.
VALEANT PHARMACEUTICALS INTL - CALL has 1 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 5,650 shares
.
Largest 8 shareholders include VERTEX ONE ASSET MANAGEMENT INC. (5,650 shares), FARLEY CAPITAL L.P. (0 shares), GROUP ONE TRADING, L.P. (1,895,100 shares), Capital Markets Trading UK LLP (322,100 shares), SIMPLEX TRADING, LLC (6,809 shares), Advisor Group, Inc. (8 shares), CMT Asset Management Ltd (0 shares), and JPMORGAN CHASE & CO (0 shares).
This table shows the top 1 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.